Related Experiment Video
Updated: Jun 14, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Ribosomal Protein S4 X-Linked as a Novel Modulator of MDM2 Stability by Suppressing MDM2 Auto-Ubiquitination and SCF
Satsuki Ryu1, Hiroki Nakashima1, Yuka Tanaka2
1Faculty of Pharmaceutical Science at Kagawa Campus, Tokushima Bunri University, 1314-1 Shido, Sanuki 769-2193, Japan.
Abstract:
Mouse double minute 2 (MDM2) is an oncoprotein that is frequently overexpressed in tumors and enhances cellular transformation. Owing to the important role of MDM2 in modulating p53 function, it is crucial to understand the mechanism underlying the regulation of MDM2 levels. We identified ribosomal protein S4X-linked (RPS4X) as a novel binding partner of MDM2 and showed that RPS4X promotes MDM2 stability. RPS4X suppressed polyubiquitination of MDM2 by suppressing homodimer formation and preventing auto-ubiquitination. Moreover, RPS4X inhibited the interaction between MDM2 and Cullin1, a scaffold protein of the Skp1-Cullin1-F-box protein (SCF) complex and an E3 ubiquitin ligase for MDM2. RPS4X expression in cells enhanced the steady-state level of MDM2 protein. RPS4X was associated not only with MDM2 but also with Cullin1 and then blocked the MDM2/Cullin1 interaction. This is the first report of an interaction between ribosomal proteins (RPs) and Cullin1. Our results contribute to the elucidation of the MDM2 stabilization mechanism in cancer cells, expanding our understanding of the new functions of RPs.
Insights
Ribosomal protein S4X-linked (RPS4X) stabilizes the oncoprotein mouse double minute 2 (MDM2) by preventing its degradation. This interaction is crucial for understanding MDM2 regulation in cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Mouse double minute 2 (MDM2) is an oncoprotein overexpressed in tumors, promoting cellular transformation.
- MDM2 plays a critical role in regulating the tumor suppressor p53.
- Understanding MDM2 regulation is vital for cancer therapy.
Purpose of the Study:
- To identify novel regulators of MDM2 stability.
- To elucidate the mechanism by which MDM2 levels are controlled.
- To explore the function of ribosomal proteins in cancer biology.
Main Methods:
- Co-immunoprecipitation to identify binding partners of MDM2.
- Ubiquitination assays to assess MDM2 degradation.
- Western blotting to measure protein levels.
- Analysis of protein-protein interactions.
Main Results:
- Ribosomal protein S4X-linked (RPS4X) was identified as a novel binding partner of MDM2.
- RPS4X enhances MDM2 stability by suppressing its polyubiquitination and auto-ubiquitination.
- RPS4X inhibits the MDM2 interaction with Cullin1, a component of the SCF E3 ubiquitin ligase complex.
- RPS4X expression increases steady-state MDM2 protein levels.
Conclusions:
- RPS4X is a novel stabilizer of MDM2, impacting its degradation pathway.
- This study reveals a new mechanism for MDM2 regulation involving ribosomal proteins.
- The findings expand the known functions of ribosomal proteins and offer insights into cancer cell mechanisms.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulation of Nuclear Protein Sorting
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Regulation of Expression at Multiple Steps
Negative Regulator Molecules

